News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Medsafe Coxib Review

Medsafe Coxib Review

Statement by Alister Brown, managing director, Merck Sharp & Dohme NZ (MSD):

“We recognize that the cardiovascular safety of the coxib and NSAID classes is an important public health issue. The data suggest an increased cardiovascular risk vs. placebo is a class effect. At the present time it is unclear if the class of drugs is limited to COX-2 selective inhibitors, all NSAIDs or NSAIDs without potent antiplatelet effects.

“There are risks and benefits with every drug, and COX-2s and NSAIDs are no different. It is important to recognize that the patients who continue to suffer with pain need effective therapies. Given the continuing need for effective pain therapy and the data currently available for ARCOXIA, we believe ARCOXIA is a suitable therapeutic option for appropriate patients in New Zealand.

“MSD currently has under way the largest arthritis trial ever conducted, called MEDAL, to assess the cardiovascular safety of ARCOXIA to the most widely used NSAID, diclofenac, in more than 23,000 patients worldwide.

“We received details of Medsafe’s preliminary assessment late on Friday. Medsafe has invited MSD to make further submissions in response to its preliminary finding, including additional data analyses and proposals for managing patient risk. MSD looks forward to working with Medsafe and contributing further to the evaluation of this class of drugs.”

Note to Editors: There are approximately 4000 New Zealand patients taking the MSD coxib ARCOXIA. When VIOXX was voluntarily withdrawn on 1 October 2004, there were approximately 12,000 New Zealand patients taking VIOXX.

© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Reuben Moss' Property is Theft! & Kaitani at The Physics Room

Property is Theft! continues Moss’ interest in the contemporary urban environment as a space controlled by pulsing and unequal flows of capital and labour. Kaitani features work by the University of Canterbury Fijian Students Association and Kulimoe’anga Stone Maka. More>>

Handcrafted Form: Rare Treasures From Japan

This unique exhibition at Expressions Whirinaki represents 90 everyday objects made by contemporary Japanese artisans who employ various traditional craft techniques made in regional workshops. The works used in daily life are crafted from raw materials with techniques appropriate to bringing out the best of its medium, balancing ease of use with aesthetic appeal. More>>

Howard Davis Article: A Musical Axis - Brahms, Wagner, Sibelius

Brahms' warm and exquisitely subtle Symphony No. 3 in F major, Wagner's irrepressibly sentimental symphonic poem Siegfried Idyll, and Sibelius' chilling and immensely challenging Violin Concerto in D minor exemplify distinct stages of development in a tangled and convoluted series of skirmishes that came to define subsequent disputes about the nature of post-Romantic orchestral writing well into the following century. More>>

Scoop Review Of Books: A Pale Ghost Writer

Reviewed by Ruth Brassington, Richard Flanagan's new novel is about a novelist hastily ghost-writing the biography of a crook about to go to trial. The reader is kept on a cliff-edge, as the narrator tries to get blood out of his stone man. More>>

New Zealand Wars Commemoration: Witi Ihimaera's Sleeps Standing Moetū

The second of several articles to mark Rā Maumahara, remembering the New Zealand Land Wars. The first was a Q&A with Vincent O’Malley, author of The Great War for New Zealand: Waikato 1800–2000. More>>




  • Wellington
  • Christchurch
  • Auckland